Korean J Urol.  2011 Jan;52(1):1-8.

Toward Evidence-Based Genetic Research on Lifelong Premature Ejaculation: A Critical Evaluation of Methodology

• Waldinger

Abstract

Recently, four premature ejaculation (PE) subtypes have been distinguished on the basis of the duration of the intravaginal ejaculation latency time (IELT). These four PE subtypes have different etiologies and pathogeneses. Genetic research on PE should consider the existence of these PE subtypes and the accurate measurement of the IELT with a stopwatch. Currently, three methods of genetic research on PE have been used. They differ in the investigated population, tool of measurement, study design, and variables of PE. From animal and human research, it is derived that the central serotonergic system "modulates" ejaculation, whereas the ejaculation (reflex) itself is probably not under direct influence of the serotonergic system, but rather under the influence of other neurotransmitter systems in the spinal cord. For genetic research on PE, it is important to take into account that the (serotonergic) modulation of the IELT is variable among men and may even be absent. This means that serotonergic genetic polymorphisms may only be found in men with PE who respond with an ejaculation delay treatment with a selective serotonin reuptake inhibitor.

Keyword

Evidence based research; Genetics; Premature ejaculation; Serotonin

MeSH Terms

Animals
Ejaculation
Genetic Research
Humans
Male
Neurotransmitter Agents
Polymorphism, Genetic
Premature Ejaculation
Serotonin
Spinal Cord
Neurotransmitter Agents
Serotonin

Reference

1. Waldinger MD, Berendsen HH, Blok BF, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998. 92:111–118.

2. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B. Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: a systematic review and meta-analysis. Int J Impot Res. 2004. 16:369–381.

3. Mos J, Van Logten J, Bloetjes K, Olivier B. The effects of idazoxan and 8-OH-DPAT on sexual behaviour and associated ultrasonic vocalizations in the rat. Neurosci Biobehav Rev. 1991. 15:505–515.

4. Janssen PK, Bakker SC, Rethelyi J, Zwinderman AH, Touw DJ, Olivier B, et al. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med. 2009. 6:276–284.

5. Schapiro B. Premature ejaculation: a review of 1130 cases. J Urol. 1943. 50:374–379.

6. Waldinger MD, Rietschel M, Nöthen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatric Genetics. 1998. 8:37–40.

7. Waldinger MD, Schweitzer DH. Changing paradigms from a historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II--proposals for DSM-V and ICD-11. J Sex Med. 2006. 3:693–705.

8. Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007. 67:547–568.

9. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999. 281:537–544.

10. Laumann EO, Paik A, Glasser DB, Kang JH, Wang T, Levinson B, et al. A cross-national study of subjective sexual well-being among older women and men: findings from the Global Study of Sexual Attitudes and Behaviors. Arch Sex Behav. 2006. 35:145–161.

11. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, et al. Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish society of Andrology Sexual Health Survey. J Sex Med. 2010. Epub ahead of print.

12. Shindel A, Nelson C, Brandes S. Urologist practice patterns in the management of premature ejaculation: a nationwide survey. J Sex Med. 2008. 5:199–205.

13. Waldinger MD. The need for a revival of psychoanalytic investigations into premature ejaculation. J Mens Health Gend. 2006. 3:390–396.

14. Waldinger MD, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med. 2008. 5:1079–1087.

15. Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007. 34:591–599.

16. Waldinger MD. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J Sex Marital Ther. 2008. 34:1–13.

17. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multi-national population survey of intravaginal ejaculation latency time. J Sex Med. 2005. 2:492–497.

18. Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009. 6:2888–2895.

19. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract. 1998. 2:287–293.

20. Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med. 2010. 7:810–815.

21. Masters WH, Johnson VE. Masters WH, Johnson VE, editors. Premature ejaculation. Human sexual inadequacy. 1970. Boston: Little, Brown;92–115.

22. Waldinger MD, Schweitzer DH. Changing paradigms from an historical DSM-III and DSM-IV view toward an evidence-based definition of premature ejaculation. Part I--validity of DSM-IV-TR. J Sex Med. 2006. 3:682–692.

23. Waldinger MD, Schweitzer DH. The DSM-IV-TR is an inadequate diagnostic tool for premature ejaculation. J Sex Med. 2007. 4:822–823.

24. Hellstrom WJ. The DSM-IV-TR is an appropriate diagnostic tool for premature ejaculation. J Sex Med. 2007. 4:252.

25. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, et al. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med. 2008. 5:1590–1606.

26. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, et al. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med. 2010. 7:2947–2969.

27. Olivier B, Chan JS, Pattij T, de Jong TR, Oosting RS, Veening JG, et al. Psycho-pharmacology of male rat sexual behavior: modeling human sexual dysfunctions? Int J Impot Res. 2006. 18:Suppl 1. S14–S23.

28. de Jong TR, Veening JG, Waldinger MD, Cools AR, Olivier B. Serotonin and the neurobiology of the ejaculatory threshold. Neurosci Biobehav Rev. 2006. 30:893–907.

29. Pattij TR, de Jong TR, Uitterdijk A, Waldinger MD, Veening JG, Cools AR, et al. Individual differences in male rat ejaculatory behaviour: searching for models to study ejaculation disorders. Eur J Neurosci. 2005. 22:724–734.

30. Waldinger MD. Lifelong premature ejaculation: definition, serotonergic neuro-transmission and drug treatment. World J Urol. 2005. 23:102–108.

31. Chan JS, Snoeren EM, Cuppen E, Waldinger MD, Olivier B, Oosting RS. The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats. J Sex Med. 2010. Epub ahead of print.

32. Coolen LM, Olivier B, Peters HJ, Veening JG. Demonstration of ejaculation-induced neural activity in the male rat brain using 5-HT1A agonist 8-OH-DPAT. Physiol Behav. 1997. 62:881–891.

33. Truitt WA, Coolen LM. Identification of a potential ejaculation generator in the spinal cord. Science. 2002. 297:1566–1569.

34. Maxwell L, Maxwell DJ, Neilson M, Kerr R. A confocal microscopic survey of serotoninergic axons in the lumbar spinal cord of the rat: co-localization with glutamate decarboxylase and neuropeptides. Neuroscience. 1996. 75:471–480.

35. Marson L, McKenna KE. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Exp Brain Res. 1992. 88:313–320.

36. Murphy AZ, Hoffman GE. Distribution of gonadal steroid receptor-containing neurons in the preoptic-periaqueductal gray-brainstem pathway: a potential circuit for the initation of male sexual behaviour. J Comp Neurol. 2001. 438:191–212.

37. Kippin TE, Sotiropoulos V, Badih J, Pfaus JG. Opposing roles of the nucleus accumbens and anterior lateral hypothalamic area in the control of sexual behaviour in the male rat. Eur J Neurosci. 2004. 19:698–704.

38. Lorrain DS, Matuszewich L, Friedman RD, Hull EM. Extracellular serotonin in the lateral hypothalamic area is increased during the postejaculatory interval and impairs copulation in male rats. J Neurosci. 1997. 17:9361–9366.

39. Allard J, Truitt WA, McKenna KE, Coolen LM. Spinal cord control of ejaculation. World J Urol. 2005. 23:119–126.

40. Waldinger MD. Four measures of investigating ejaculatory performance. J Sex Med. 2007. 4:520.

41. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. The majority of men with lifelong premature ejaculation prefer daily drug treatment: an observational study in a consecutive group of Dutch men. J Sex Med. 2007. 4:1028–1037.

42. Jern P, Santtilla P, Witting K, Harlaar N, Johansson A, von der Pahlen B, et al. Premature and delayed ejaculation: genetic and environmental effects in a population-based sample of Finnish twins. J Sex Med. 2007. 4:1739–1749.

43. Jern P, Santtilla P, Johansson A, Varjonen M, Witting K, Algars M, et al. Indicators of premature ejaculation and their associations with sexual distress in a population-based sample of young twins and their siblings. J Sex Med. 2008. 5:2191–2201.

44. Jern P, Santtilla P, Johansson A, Varjonen M, Witting K, von der Pahlen B, et al. Subjectively measured ejaculation latency time and its association with different sexual activities while controlling for age and relationship length. J Sex Med. 2009. 6:2568–2578.

45. Santtila P, Jern P, Westberg L, Walum H, Pedersen CT, Eriksson E, et al. The dopamine transporter gene (DAT1) polymorphism is associated with premature ejaculation. J Sex Med. 2010. 7:1538–1546.

46. Ozbek E, Tasci AI, Tugcu V, Ilbey YO, Simsek A, Ozcan L, et al. Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population. Asian J Androl. 2009. 11:351–355.

47. Luo S, Lu Y, Wang F, Xie Z, Huang X, Dong Q, et al. Association between polymorphisms in the serotonin 2C receptor gene and premature ejaculation in Han Chinese subjects. Urol Int. 2010. 85:204–208.

48. Waldinger MD, Janssen PK, Schweitzer DH. Hardy Weinberg equilibrium in genetic PE research remains critical to avoid misinterpretation. Asian J Androl. 2009. 11:524.

49. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003. 15:309–313.